Steward Partners Investment Advisory, LLC Vertex Pharmaceuticals Inc Transaction History

Steward Partners Investment Advisory, LLC

$10.9 Billion
Q1 2025

A detailed history of Steward Partners Investment Advisory, LLC transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Steward Partners Investment Advisory, LLC holds 41,033 shares of VRTX stock, worth $17.9 Million. This represents 0.18% of its overall portfolio holdings.

Number of Shares

41,033

Previous 39,808 3.08%

Holding current value

$17.9 Million

Previous $16 Million 24.1%

% of portfolio

0.18%

Previous 0.15%

33 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 13, 2025	BUY	$402.49 - $513.76 $493,050 - $629,356	1,225 Added 3.08%	41,033 $19.9 Million
Q4 2024 Feb 06, 2025	SELL	$396.64 - $516.74 $1.96 Million - $2.56 Million	-4,948 Reduced 11.06%	39,808 $16 Million
Q3 2024 Nov 14, 2024	BUY	$460.0 - $505.78 $1.87 Million - $2.06 Million	4,075 Added 10.02%	44,756 $20.8 Million
Q2 2024 Aug 08, 2024	SELL	$392.81 - $485.53 $229,793 - $284,035	-585 Reduced 1.42%	40,681 $19.1 Million
Q1 2024 May 15, 2024	BUY	$407.69 - $446.08 $2.57 Million - $2.81 Million	6,299 Added 18.01%	41,266 $17.2 Million
Q4 2023 Feb 12, 2024	BUY	$343.0 - $410.68 $2.57 Million - $3.08 Million	7,504 Added 27.32%	34,967 $14.2 Million
Q3 2023 Nov 13, 2023	BUY	$338.18 - $362.46 $2.24 Million - $2.4 Million	6,619 Added 31.75%	27,463 $9.55 Million
Q2 2023 Aug 14, 2023	BUY	$314.42 - $351.91 $2.27 Million - $2.54 Million	7,209 Added 52.87%	20,844 $7.34 Million
Q1 2023 May 15, 2023	BUY	$283.23 - $323.1 $548,899 - $626,167	1,938 Added 16.57%	13,635 $4.3 Million
Q4 2022 Feb 15, 2023	BUY	$285.76 - $321.48 $1.4 Million - $1.58 Million	4,904 Added 72.19%	11,697 $3.38 Million
Q3 2022 Nov 10, 2022	SELL	$273.83 - $305.53 $27,930 - $31,164	-102 Reduced 1.48%	6,793 $1.97 Million
Q2 2022 Aug 04, 2022	SELL	$234.96 - $292.55 $97,273 - $121,115	-414 Reduced 5.66%	6,895 $1.94 Million
Q1 2022 May 02, 2022	BUY	$221.42 - $260.97 $863,095 - $1.02 Million	3,898 Added 114.28%	7,309 $1.91 Million
Q4 2021 Feb 08, 2022	SELL	$177.01 - $223.45 $49,208 - $62,119	-278 Reduced 7.54%	3,411 $749,000
Q3 2021 Nov 12, 2021	SELL	$181.39 - $202.99 $121,712 - $136,206	-671 Reduced 15.39%	3,689 $669,000
Q2 2021 Aug 13, 2021	SELL	$187.49 - $221.1 $514,285 - $606,477	-2,743 Reduced 38.62%	4,360 $879,000
Q1 2021 May 14, 2021	SELL	$207.02 - $241.31 $643,625 - $750,232	-3,109 Reduced 30.44%	7,103 $1.53 Million
Q4 2020 Feb 11, 2021	BUY	$207.01 - $276.09 $286,087 - $381,556	1,382 Added 15.65%	10,212 $2.41 Million
Q3 2020 Oct 30, 2020	SELL	$255.65 - $303.1 $139,584 - $165,492	-546 Reduced 5.82%	8,830 $2.4 Million
Q2 2020 Aug 06, 2020	BUY	$225.48 - $295.8 $1.05 Million - $1.37 Million	4,646 Added 98.22%	9,376 $2.72 Million
Q1 2020 Apr 29, 2020	BUY	$199.77 - $247.81 $70,718 - $87,724	354 Added 8.09%	4,730 $1.13 Million
Q4 2019 Jan 17, 2020	BUY	$166.71 - $223.91 $7,501 - $10,075	45 Added 1.04%	4,376 $958,000
Q3 2019 Oct 30, 2019	BUY	$166.23 - $187.09 $186,842 - $210,289	1,124 Added 35.05%	4,331 $733,000
Q2 2019 Jul 25, 2019	BUY	$164.61 - $190.37 $195,721 - $226,349	1,189 Added 58.92%	3,207 $588,000
Q1 2019 Apr 30, 2019	SELL	$163.73 - $194.7 $5,075 - $6,035	-31 Reduced 1.51%	2,018 $371,000
Q4 2018 Jan 15, 2019	BUY	$151.91 - $192.21 $21,267 - $26,909	140 Added 7.33%	2,049 $339,000
Q3 2018 Oct 23, 2018	BUY	$167.73 - $192.74 $2,180 - $2,505	13 Added 0.69%	1,909 $368,000
Q2 2018 Jul 20, 2018	SELL	$145.72 - $169.96 $10,346 - $12,067	-71 Reduced 3.61%	1,896 $322,000
Q1 2018 Apr 20, 2018	BUY	$151.6 - $177.13 $35,474 - $41,448	234 Added 13.5%	1,967 $320,000
Q4 2017 Jan 19, 2018	BUY	$137.28 - $155.55 $28,966 - $32,821	211 Added 13.86%	1,733 $259,000
Q3 2017 Nov 22, 2017	BUY	$148.13 - $162.24 $29,774 - $32,610	201 Added 15.22%	1,522 $231,000
Q2 2017 Nov 22, 2017	BUY	N/A	118 Added 9.81%	1,321 $170,000
Q1 2017 Nov 22, 2017	BUY	N/A	1,203	1,203 $131,000

Others Institutions Holding VRTX

# of Institutions

1,830

Shares Held

233M

Call Options Held

1.38M

Put Options Held

1.08M

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $112B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Steward Partners Investment Advisory, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Steward Partners Investment Advisory, LLC with notifications on news.

Account

Steward Partners Investment Advisory, LLC Vertex Pharmaceuticals Inc Transaction History